PAR18 A FIVE-YEAR LONGITUDINAL ANALYSIS COMPARING DOSE CHANGES FOR PATIENTS WITH RHEUMATOID ARTHRITIS TAKING INFLIXIMAB IN A MEDICARE AND IN A COMMERCIALLY INSURED POPULATION
Abstract
Authors
K Nair B Tang J Van Den Bos V Zhang J Saseen M Rahman